{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T16:44:51Z","timestamp":1726505091362},"reference-count":9,"publisher":"California Digital Library (CDL)","issue":"4","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Introduction: Supraventricular tachycardia (SVT) is a condition requiring emergency care in neonates.\n\nCase Report: We describe a successfully treated case of neonatal SVT in a four-week-old neonate using the novel adenosine administration method. This technique is potentially easier to facilitate and does not require equipment such as a stopcock. Adenosine 0.2 milligrams per kilogram was drawn up into a syringe containing 0.9% sodium chloride to a total volume of 3 milliliters. Once administered, the patient had near-immediate return to normal sinus rhythm without sequelae. \n\nConclusion: This case demonstrates that the single-syringe method appears potentially safe and effective in neonates.<\/jats:p>","DOI":"10.5811\/cpcem.2020.9.48829","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T06:12:05Z","timestamp":1605593525000},"page":"617-619","source":"Crossref","is-referenced-by-count":1,"title":["A Case Report of Neonatal Supraventricular Tachycardia Resolved with Single-Syringe Adenosine"],"prefix":"10.5811","volume":"4","author":[{"given":"Marc","family":"McDowell","sequence":"first","affiliation":[{"name":"Advocate Children\u2019s Hospital, Department of Emergency Medicine, Oak Lawn, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasneem","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Advocate Children\u2019s Hospital, Department of Emergency Medicine, Oak Lawn, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bill","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Advocate Children\u2019s Hospital, Department of Emergency Medicine, Oak Lawn, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Staley","sequence":"additional","affiliation":[{"name":"Advocate Children\u2019s Hospital, Department of Emergency Medicine, Oak Lawn, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"29705","published-online":{"date-parts":[[2020,10,20]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Lau EW. Infraatrial supraventricular tachycardias: mechanisms, diagnosis, and management.\u00a0Pacing Clin Electrophysiol. 2008;31(4):490-8.","DOI":"10.1111\/j.1540-8159.2008.01020.x"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC\/AHA\/HRS Guideline for the Management of Adult Patients with Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society [published correction appears in Circulation. 2016;134(11):e232-3].\u00a0Circulation. 2016;133(14):e471-505.","DOI":"10.1161\/cir.0000000000000447"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Wu MH, Chen HC, Kao FY, et al. Postnatal cumulative incidence of supraventricular tachycardia in a general pediatric population: a national birth cohort database study.\u00a0Heart Rhythm. 2016;13(10):2070-5.","DOI":"10.1016\/j.hrthm.2016.06.006"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Link MS. Clinical practice. Evaluation and initial treatment of supraventricular tachycardia.\u00a0N Engl J Med. 2012;367(15):1438-48.","DOI":"10.1056\/NEJMcp1111259"},{"key":"ref4","unstructured":"U.S. Food and Drug Adminstration (FDA). Adenocard injection solution, adenosine injection solution. 2005. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/019937s026lbl.pdf. Accessed April 11, 2020."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Berg MD, Schexnayder SM, Chameides L, et al. Part 13: Pediatric Basic Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.\u00a0Circulation. 2010;122(18 Suppl 3):S862-75.","DOI":"10.1161\/circulationaha.110.971085"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Gausche M, Persse DE, Sugarman T, et al. Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia. Ann Emerg Med 1994;24(2):183-9.","DOI":"10.1016\/s0196-0644(94)70128-8"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Weberding NT, Saladino RA, Minnigh MB, et al. Adenosine administration with a stopcock technique delivers lower-than-intended drug\u00a0doses.\u00a0Ann Emerg Med. 2018;71(2):220-4.","DOI":"10.1016\/j.annemergmed.2017.09.002"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"McDowell M, Mokszycki R, Greenberg A, et al. Single-syringe administration of diluted adenosine.\u00a0Acad Emerg Med. 2020;27(1):61-3.","DOI":"10.1111\/acem.13879"}],"container-title":["Clinical Practice and Cases in Emergency Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T20:22:06Z","timestamp":1605817326000},"score":1,"resource":{"primary":{"URL":"https:\/\/escholarship.org\/uc\/item\/6df9m4jg"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":9,"issue-title":["Clinical Practice and Cases in Emergency Medicine"],"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,11,10]]}},"URL":"https:\/\/doi.org\/10.5811\/cpcem.2020.9.48829","relation":{},"ISSN":["2474-252X","2474-252X"],"issn-type":[{"type":"electronic","value":"2474-252X"},{"type":"print","value":"2474-252X"}],"subject":[],"published":{"date-parts":[[2020,10,20]]}}}